T2 Biosystems, Inc.
T2 Biosystems is focused on developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics.
Website
Headquarters
101 HARTWELL AVE LEXINGTON, MA 02421 UNITED STATES
3
231 Andover Street Wilmington, MA 0188
Company Size
100 - 249
-
DEC 03, 2024 | 7:00 AM
During the webinar, Dr. Snežana Jovanović will share her experience with T2 Biosystems sepsis diagnostics. Through case studies, participants will examine the role of early diagnosis of bloo... -
FEB 14, 2024 | 7:00 AM
Invasive candidiasis and candidemia are associated with a high rate of patient morbidity and mortality, but earlier initiation of antifungal therapy can significantly improve patient outcome...
-
OCT 17, 2023 | 6:00 AM
During this presentation, the speaker will provide insights into the clinical utility of the T2Bacteria and T2Resistance Panels in the intensive care unit (ICU), including real-world clinica...
-
DEC 14, 2022 | 12:00 PMC.E. CREDITS
Date: December 14, 2022 Time: 12:00pm (PST), 3:00pm (EST), 9:00pm (CET) Adopting novel technologies is essential for improving patient outcomes, but the key to sustainable success is through...
-
MAR 16, 2022 | 7:00 AM
Date: March 16, 2022 Time: 07:00am (PDT), 10:00am (EDT), 4:00pm (CEDT) During this webinar, we will provide an overview of the current landscape of sepsis management and the impact of rapid...
-
JUN 20, 2018 | 7:00 AM
DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
-
OCT 03, 2017 | 3:00 AM
DATE: October 3, 2017TIME: 03:00am PDT, 06:00am EDT, 12:00pm CEST(Europe)Learn from renowned clinical expert, Patricia Muñoz, MD, PhD, how incorporating the T2Sepsis Solution int...
-
MAY 22, 2017 | 10:00 AM
DATE: May 22, 2017TIME: 10:00am PT, 1:00pm ETLearn from renowned clinical expert, George J. Alangaden, M.D., as he discusses how Henry Ford Health System (HFHS) implemented T2MR and the...
-
JAN 31, 2017 | 10:00 AM
DATE: January 31, 2017TIME: 10:00am PT/1:00pm ETLearn from renowned clinical expert, Dr. Michael A. Pfaller, as he discusses the critical role of diagnostics and antimicrobial stewardsh...
